Original scientific paper
https://doi.org/10.1080/1331677X.2023.2182808
Chinese companies’ transparency under sustainable development goals: the role of asset impairment and biological assets in audit
Liping Wu
Xiahui Wang
Hu Kai
Chen Yang
Oleksii Lyulyov
Tetyana Pimonenko
Abstract
The paper aims to analyse the role of asset impairment and biological
assets in the company’s audit and to estimate the impact of
asset impairment losses and biological asset scale on audit fees. The
object of the investigation was A-share listed companies from 2012
to 2021 in China. The study analysed 370 listed companies to obtain
28741 observations, of which 367 listed companies had 1854 observations
with biological assets. The study applied the fixed effect
model, three-step mediation test, Sobel mediation test and PSM
matching test. The results show that asset impairment loss and biological
asset size are significantly positively correlated with audit
fees, and the scale of biological assets will strengthen the positive
correlation between asset impairment loss and audit fees. It is further
found that asset impairment and biological assets positively affect
audit fees through two parallel intermediary paths of "audit working
hours" and "violations". Finally, based on the above findings, this
paper also attempts to make optimisation recommendations for the
four relevant stakeholders involved in the audit. This paper contributes
to improving accounting standards for biological assets and
enriching the research on audit pricing based on the empirical justifications
of their role in the company’s audit.
Keywords
Accountable institutions; auditing fee; financial statement; financial access; material flow accounting; resource efficiency; transparent reporting
Hrčak ID:
306880
URI
Publication date:
30.4.2023.
Visits: 592 *